|
End-of-day quote
Mexican S.E.
2026-09-09
|
5-day change | 1st Jan Change | ||
| 1,850.00 MXN | -17.02% |
|
-.--% | -25.11% |
| 10-05 | UBS Adjusts Price Target on Xylem to $112 From $138, Keeps Neutral Rating | MT |
| 10-01 | BNP Paribas Adjusts Price Target on Xylem to $145 From $160, Maintains Outperform Rating | MT |
Company Valuation: Xylem Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 21,625 | 19,927 | 27,570 | 28,186 | 33,156 | 23,914 | - | - |
| Change | - | -7.85% | 38.35% | 2.24% | 17.63% | -27.87% | - | - |
| Enterprise Value (EV) 1 | 22,716 | 20,863 | 28,835 | 29,081 | 33,619 | 25,194 | 24,278 | 23,266 |
| Change | - | -8.16% | 38.21% | 0.86% | 15.6% | -25.06% | -3.63% | -4.17% |
| P/E | 51x | 56.4x | 41x | 31.8x | 34.7x | 22.4x | 19.1x | 16.8x |
| PBR | 6.72x | 5.7x | 2.72x | 2.65x | 2.89x | 2.24x | 2.11x | 2.02x |
| PEG | - | -3.4x | 1x | 1x | 4.69x | 1.3x | 1.1x | 1.2x |
| Capitalization / Revenue | 4.16x | 3.61x | 3.74x | 3.29x | 3.67x | 2.6x | 2.48x | 2.36x |
| EV / Revenue | 4.37x | 3.78x | 3.92x | 3.4x | 3.72x | 2.74x | 2.52x | 2.3x |
| EV / EBITDA | 26.5x | 23x | 20.7x | 16.5x | 16.7x | 11.8x | 10.5x | 9.26x |
| EV / EBIT | 37.2x | 31x | 26.9x | 21.2x | 20.9x | 14.5x | 12.8x | 11.2x |
| EV / FCF | 68.8x | 53.8x | 48.1x | 30.9x | 36.9x | 26.5x | 18.9x | 15.3x |
| FCF Yield | 1.45% | 1.86% | 2.08% | 3.24% | 2.71% | 3.77% | 5.29% | 6.54% |
| Dividend per Share 2 | 1.12 | 1.2 | 1.32 | 1.44 | 1.6 | 1.723 | 1.863 | 2.024 |
| Rate of return | 0.93% | 1.09% | 1.15% | 1.24% | 1.17% | 1.68% | 1.82% | 1.98% |
| EPS 2 | 2.35 | 1.96 | 2.79 | 3.65 | 3.92 | 4.573 | 5.365 | 6.109 |
| Distribution rate | 47.7% | 61.2% | 47.3% | 39.5% | 40.8% | 37.7% | 34.7% | 33.1% |
| Net sales 1 | 5,195 | 5,522 | 7,364 | 8,562 | 9,035 | 9,205 | 9,624 | 10,133 |
| EBITDA 1 | 856 | 908 | 1,392 | 1,763 | 2,009 | 2,138 | 2,305 | 2,514 |
| EBIT 1 | 611 | 672 | 1,072 | 1,373 | 1,612 | 1,737 | 1,893 | 2,069 |
| Net income 1 | 427 | 355 | 609 | 890 | 957 | 1,085 | 1,277 | 1,429 |
| Net Debt 1 | 1,091 | 936 | 1,265 | 895 | 463 | 1,280 | 364.4 | -648.1 |
| Reference price 2 | 119.92 | 110.57 | 114.36 | 116.02 | 136.18 | 102.42 | 102.42 | 102.42 |
| Nbr of stocks (in thousands) | 180,325 | 180,222 | 241,078 | 242,945 | 243,469 | 233,487 | - | - |
| Announcement Date | 2/3/22 | 2/7/23 | 2/6/24 | 2/4/25 | 2/10/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 31.16x | 5.43x | 19.69x | 0.83% | 123B | ||
| 34.94x | 5.49x | 20.8x | 1.54% | 97.45B | ||
| 45.06x | 9.14x | 26.74x | -.--% | 65.48B | ||
| 27.58x | 3.16x | 18.24x | 0.75% | 60.3B | ||
| 40.2x | 6.25x | 27.6x | 1.93% | 58.24B | ||
| 27.51x | 5.07x | 17.77x | 2.19% | 35.94B | ||
| 20.6x | 1.76x | 12.69x | 2.28% | 29.97B | ||
| 30.09x | 4.01x | 15.13x | 0.11% | 29.52B | ||
| 21.04x | 3.65x | 11.66x | 1.45% | 29.28B | ||
| Average | 30.91x | 4.88x | 18.93x | 1.23% | 58.76B | |
| Weighted average by Cap. | 32.70x | 5.32x | 20.25x | 1.14% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- XYL Stock
- XYL * Stock
- Valuation Xylem Inc.
Select your edition
All financial news and data tailored to specific country editions
















